OpenAI and the FDA are reportedly discussing AI for drug evaluations | TechCrunch
TechCrunch
OpenAI has reportedly met with officials from the Food and Drug Administration to discuss how AI could speed up drug evaluations.
Full story content is not available.
Visit Original Source